We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$606M
AUM Growth
-$147M
(-20%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-25.06%
Top 10 Holdings %
Top 10 Hldgs %
26.18%
Holding
657
New
70
Increased
165
Reduced
211
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$24.8M |
| 2 |
Constellation Brands
STZ
|
+$12.7M |
| 3 |
HCA Healthcare
HCA
|
+$12.2M |
| 4 |
Avery Dennison
AVY
|
+$12M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$15.3M |
| 2 |
Masco
MAS
|
+$14.6M |
| 3 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$14.6M |
| 4 |
Cintas
CTAS
|
+$14.5M |
| 5 |
United Parcel Service
UPS
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 16.62% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Financials | 10.34% |
| 4 | Communication Services | 8.36% |
| 5 | Materials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAP
176
The Gap Inc
GAP
$7.3B
| $278K | 0.05% |
13,100
-11,640
| -47% | -$248K |
|
177
Eli Lilly
LLY
$1.08T
| $274K | 0.05% |
3,479
-2,396
| -41% | -$180K |
|
178
iShares MSCI Sweden ETF
EWD
$534M
| $271K | 0.04% |
10,138
+5,938
| +141% | +$174K |
|
179
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $271K | 0.04% |
2,400
+267
| +13% | +$29.5K |
|
180
iShares MSCI Singapore ETF
EWS
$1.04B
| $269K | 0.04% |
12,362
+10,320
| +505% | +$220K |
|
181
Cardinal Health
CAH
$53.7B
| $268K | 0.04% |
3,432
-323
| -9% | -$25.8K |
|
182
Entergy
ETR
$50.3B
| $265K | 0.04% |
6,518
+506
| +8% | +$19.4K |
|
183
Walt Disney
DIS
$171B
| $262K | 0.04% |
+2,676
| New | +$268K |
|
184
TripAdvisor
TRIP
$1.7B
| $258K | 0.04% |
4,009
+8
| +0.2% | +$518 |
|
185
Gerdau
GGB
$9.54B
| $255K | 0.04% |
176,500
-38,466
| -18% | -$56.7K |
|
186
Boeing
BA
$169B
| $253K | 0.04% |
1,948
-930
| -32% | -$121K |
|
187
Halliburton
HAL
$26.1B
| $249K | 0.04% |
5,493
-36,124
| -87% | -$1.49M |
|
188
Johnson & Johnson
JNJ
$640B
| $246K | 0.04% |
+2,027
| New | +$230K |
|
189
iShares MSCI Australia ETF
EWA
$1.38B
| $245K | 0.04% |
12,790
+476
| +4% | +$9.29K |
|
190
BlackBerry
BB
$4.58B
| $236K | 0.04% |
35,250
+7,957
| +29% | +$55.6K |
|
191
BBVA Argentina
BBAR
$3.85B
| $231K | 0.04% |
11,188
+4,000
| +56% | +$81.1K |
|
192
iShares MSCI Taiwan ETF
EWT
$9.13B
| $229K | 0.04% |
8,156
+4,947
| +154% | +$132K |
|
193
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.41B
| $219K | 0.04% |
5,032
+194
| +4% | +$8.42K |
|
194
Berkshire Hathaway Class A
BRK.A
$1.1T
| $217K | 0.04% |
1
| – | – |
|
|
PXD
195
DELISTED
Pioneer Natural Resource Co.
PXD
| $213K | 0.04% |
1,406
-355
| -20% | -$55.7K |
|
196
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$182M
| $209K | 0.03% |
4,938
-116
| -2% | -$5.82K |
|
197
AGNC Investment
AGNC
$12.7B
| $200K | 0.03% |
10,099
-826
| -8% | -$15.6K |
|
198
Chord Energy
CHRD
$7.68B
| $196K | 0.03% |
21,022
-5,801
| -22% | -$55K |
|
199
BP
BP
$112B
| $196K | 0.03% |
+6,546
| New | +$176K |
|
200
Bristol-Myers Squibb
BMY
$129B
| $194K | 0.03% |
2,640
-2,505
| -49% | -$177K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2016 Portfolio in Review
As of Q2 2016, Exane Derivatives held 657 positions worth $606M, down 20% from $753M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Exane Derivatives withdrew a net $152M in Q2 2016, closing 108 positions and reducing 211 holdings. Its most notable exit was Masco, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Exane Derivatives opened a new position in UBS Group worth $20.8M.
- Exane Derivatives's largest Q2 2016 buy was UBS Group: 1,623,142 shares worth $20.8M.
- Exane Derivatives added most to Constellation Brands in Q2 2016, an estimated $12.7M increase.
- Exane Derivatives's biggest Q2 2016 reduction was Applied Materials, cutting an estimated $15.3M.
- Exane Derivatives fully exited Masco in Q2 2016, selling an estimated $14.6M.
- Exane Derivatives's ten largest holdings make up 26% of its $606M portfolio in Q2 2016.
- Exane Derivatives opened 70 new positions and closed 108 in Q2 2016.
- Exane Derivatives's portfolio value fell 20% quarter-over-quarter to $606M.
Based on Exane Derivatives's 13F filing for Q2 2016, filed 3 Aug 2016.